HCN Oncology Essentials: FDA: Let’s Meet on Gene Therapies | Transformed Lymphoma Strategies | Medical Records LockoutNovember 16, 2021 | Oncology Hematology Recent Gene Therapy Deaths Raise Safety Concerns The U.S. Food and Drug Administration (FDA) held a two-day public meeting to discuss managing the potential side effects of gene therapies following the death of a boy with a rare neuromuscular disease. High doses of gene therapies are known to cause liver damage, and recent studies have also found a potential long-term cancer risk in mice and dogs treated with gene therapies. Read full article Hematology Evolving Strategies for the Management of Transformed Lymphoma Clinical Advances in Hematology & Oncology talks with Sonali M. Smith, MD, an Elwood V. Jensen Professor in Medicine and Chief, Section of Hematology/Oncology at the University of Chicago, about all things transformed lymphoma, including risk factors, distinguishing characteristics, pathogenesis, traditional treatment approaches, treatment goals, new treatment strategies, and other promising areas of research. Read full article Hematology Access Denied: One Family’s Struggle with Medical Records The Journal of Clinical Oncology has a heartfelt account of one family’s struggle to access medical records after the death of a child from a brain tumor. Closing down online access to medical records is a common practice at hospitals and healthcare clinics following the death of a patient, often to the pain of family members who still have questions and seek answers. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS